As a company listed on the Euronext Growth market in Paris, Europlasma undertakes to providing the financial community with regular, transparent and accessible information and in compliance with stock market regulations
Europlasma today announces its results for the year ended December 31, 2017, approved by the Board of Directors on April 17, 2018 and audited by the Auditors.
